Head-to-Head

Innoviva, Inc. Common Stock vs. Johnson & Johnson

INVA

Innoviva, Inc. Common Stock

$21.34 +2.89%

VS JNJ

Johnson & Johnson

$272.30 +0.40%

Innoviva, Inc. Common Stock (INVA) comes out ahead, leading on 7 of 11 compared factors.

Size & Scale

INVAJNJ
Market Cap $1.50 billion $653.61 billion
Revenue (TTM) $440.00 million $97.93 billion
Net Income (TTM) $357.24 million $21.04 billion

JNJ leads on 3 of 3 size & scale factors.

Valuation

INVAJNJ
P/E Ratio 5.19 31.59
Price / Book 1.21 7.69
Price / Sales 3.41 6.67

INVA leads on 3 of 3 valuation factors.

Profitability

INVAJNJ
Net Margin 81.19% 21.48%
Return on Equity 28.97% 24.76%

INVA leads on 2 of 2 profitability factors.

Dividend

INVAJNJ
Dividend Yield 4.69% 1.97%
Payout Ratio 24.33 62.18

INVA leads on 2 of 2 dividend factors.

Risk & Sentiment

INVAJNJ
Short Interest 19.43% 0.67%

JNJ leads on 1 of 1 risk & sentiment factors.

Dig deeper: INVA overview, INVA financials, JNJ overview, JNJ financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.